Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Chrysosplenol D, an efflux pump inhibitor that can potentiate the activity of commercially important antibiotics and antimalarials.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 97.00 | |
5 mg | In stock | $ 263.00 | |
10 mg | In stock | $ 413.00 | |
25 mg | In stock | $ 676.00 | |
50 mg | In stock | $ 943.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 278.00 |
Description | Chrysosplenol D, an efflux pump inhibitor that can potentiate the activity of commercially important antibiotics and antimalarials. |
Targets&IC50 | viability:11.6 µM(MDA-MB-231 TNBC cells) |
In vitro | Trace amounts of the antimalarial sesquiterpene lactone artemisinin may account for the activity of the n-hexane fraction but only the methoxylated flavonoids artemetin, chrysoplenetin, chrysosplenol-D and cirsilineol can account for the activity of the chloroform extract. These purified flavonoids were found to have IC50 values at 2.4 - 6.5 x 10(-5)M against P. falciparum in vitro compared with an IC50 value of about 3 x 10(-8)M for purified artimisinin[1] |
Source |
Molecular Weight | 360.31 |
Formula | C18H16O8 |
CAS No. | 14965-20-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (152.65 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Chrysosplenol D 14965-20-9 Immunology/Inflammation MAPK NF-Κb JNK NF-κB IL Receptor cancer Apoptosis inhibit ERK1/2 Inhibitor antitrypanosomal breast anti-inflammatory inhibitor